U.S. flag

An official website of the United States government

NM_020549.5(CHAT):c.1663G>A (p.Glu555Lys) AND Familial infantile myasthenia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 26, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000804335.3

Allele description [Variation Report for NM_020549.5(CHAT):c.1663G>A (p.Glu555Lys)]

NM_020549.5(CHAT):c.1663G>A (p.Glu555Lys)

Gene:
CHAT:choline O-acetyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q11.23
Genomic location:
Preferred name:
NM_020549.5(CHAT):c.1663G>A (p.Glu555Lys)
HGVS:
  • NC_000010.11:g.49655123G>A
  • NG_011797.1:g.51029G>A
  • NM_001142929.2:c.1309G>A
  • NM_001142933.2:c.1417G>A
  • NM_001142934.2:c.1309G>A
  • NM_020549.5:c.1663G>AMANE SELECT
  • NM_020984.4:c.1309G>A
  • NM_020985.4:c.1309G>A
  • NM_020986.4:c.1309G>A
  • NP_001136401.2:p.Glu437Lys
  • NP_001136405.2:p.Glu473Lys
  • NP_001136406.2:p.Glu437Lys
  • NP_065574.3:p.Glu555Lys
  • NP_065574.4:p.Glu555Lys
  • NP_066264.4:p.Glu437Lys
  • NP_066265.4:p.Glu437Lys
  • NP_066266.4:p.Glu437Lys
  • NC_000010.10:g.50863169G>A
  • NM_020549.4:c.1663G>A
Protein change:
E437K
Links:
dbSNP: rs757303526
NCBI 1000 Genomes Browser:
rs757303526
Molecular consequence:
  • NM_001142929.2:c.1309G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001142933.2:c.1417G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001142934.2:c.1309G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020549.5:c.1663G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020984.4:c.1309G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020985.4:c.1309G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020986.4:c.1309G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial infantile myasthenia (CMS6)
Synonyms:
Congenital myasthenic syndrome with episodic apnea; Myasthenic syndrome congenital associated with episodic apnea; Myasthenic syndrome, presynaptic, congenital, associated with episodic apnea; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009689; MedGen: C0393929; Orphanet: 590; OMIM: 254210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000944239Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Oct 26, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A rapid gene sequencing panel strategy to facilitate precision neonatal medicine.

Brunelli L, Mao R, Jenkins SM, Bleyl SB, Dames SA, Miller CE, Ostrander B, Tvrdik T, Andrews S, Flores J, Patel S, Gudgeon JM, Schaefer S.

Am J Med Genet A. 2017 Jul;173(7):1979-1982. doi: 10.1002/ajmg.a.38259. Epub 2017 May 12. No abstract available.

PubMed [citation]
PMID:
28497657

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000944239.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 555 of the CHAT protein (p.Glu555Lys). This variant is present in population databases (rs757303526, gnomAD 0.003%). This missense change has been observed in individual(s) with congenital myasthenic syndrome (PMID: 28497657). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 649407). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHAT protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024